Iceland Lung Cancer Survival Rates News Monitoring

Get by Email • RSS

No articles found

07 days 16:16:33

Featured Releases

Got News to Share? · Submit · See All

Published on March 31, 2025 - 11:00 GMT

Atavistik Bio Announces Appointment of William Sellers, M.D. to its Scientific Advisory Board

Dr. William Sellers is a leading cancer researcher who currently serves as a Core Institute member and Director of the cancer program at the Broad Institute and a professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School He brings …

Distribution channels: Technology ...
Published on March 29, 2025 - 01:35 GMT

Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …

Distribution channels:

Published on March 28, 2025 - 20:10 GMT

Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

– Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer – – Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer …

Distribution channels:
Published on March 28, 2025 - 14:28 GMT

Microcarriers Market Size Set to Expand to USD 4.17 Billion by 2030, Driven by Cell Therapy Demand and Strategic ...

US & Canada, March 28, 2025 (GLOBE NEWSWIRE) -- US & Canada, Mar, 21, 2025 (GlobeNewswire) -- According to a comprehensive report from The Insight Partners, “Microcarriers Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 28, 2025 - 12:30 GMT

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial results for the fiscal year ended December 31, 2024, …

Distribution channels:
Published on March 28, 2025 - 11:30 GMT

LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

Focused on the evaluation of strategic alternatives Adopted a restructuring plan to extend capital resources, incurring a reduction in workforce of 30% to support the evaluation of strategic options and the Phase 1 study for LAVA-1266 Phase 1 enrollment in …

Distribution channels:
Published on March 27, 2025 - 14:45 GMT

Global Radiotherapy Market Forecast: Key Growth Drivers, Trends, And Opportunities From 2025 To 2034

The Business Research Company's Radiotherapy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 27, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 27, 2025 - 14:46 GMT

Key Market Driver In Oncolytic Adenovirus Industry 2025: Surge In Cancer Diagnoses Drives Breakthroughs

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout. LONDON, GREATER LONDON, UNITED KINGDOM, March 27, 2025 /⁨EINPresswire.com⁩/ -- The oncolytic adenovirus global market is projected to reach $132.87 billion in …

Distribution channels: Business & Economy, Companies ...

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 798,702,517 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 31, 2025 - 11:00 GMT

Boon-Chapman Strengthens Leadership Team with Appointment of New General Counsel

AUSTIN, TX, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- Boon-Chapman, a leader in claims administration, cost containment, and care navigation, is pleased to announce the appointment of Tim McConville as General Counsel, effective March …

Distribution channels: Banking, Finance & Investment Industry, Companies ...
Published on March 31, 2025 - 10:00 GMT

New Resources for Psychedelic Therapy: Matt Zemon and Ken Weingardt Unveil The Beginner’s Guide to Psychedelics

Empowering Individuals and Professionals with Practical Tools for Psychedelic Preparation, Integration, and Healing. CHAPEL HILL, NC, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- Matt Zemon, MSc, educator and author in psychedelic …

Distribution channels: Book Publishing Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 10:00 GMT

Planet TV Studios ‘New Frontiers’ Episode on Mirion Technologies, Accelerating Advancements in Precision Medicine, ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. Mirion Technologies, Inc. in New Frontiers Episode Airing Q2 2025 on Bloomberg. ATLANTA, GA, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- Planet TV …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 10:00 GMT

Biomed Industries CEO to Chair NeuroSciences 2025 and Present Breakthrough Research on Alzheimer’s Disease and Obesity

Biomed Industries, Inc. CEO to Chair NeuroSciences 2025 and Present Groundbreaking Research on Alzheimer’s, Obesity, and Rett Syndrome SAN JOSE, CA, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- Biomed Industries, Inc. (Biomed) announced …

Distribution channels: Chemical Industry, Companies ...
Published on March 31, 2025 - 08:05 GMT

World’s First: NOCCI and ERIC Introduce Dimensional Energy Work to Activate the Pineal Gland and Awaken the Third Eye

A Breakthrough in Human Consciousness: Remote Energy Work Unlocks the Third Eye and Initiates Dimensional Contact MUNICH, BAVARIA, GERMANY, March 31, 2025 /⁨EINPresswire.com⁩/ -- International spiritual leaders NOCCI and her soul partner ERIC have …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on March 31, 2025 - 08:00 GMT

Ascilion to present at the 8th International Conference on Microneedles in Brisbane

Ascilion's products for dermal interstitial fluid sampling will be the focus of six different presentations at the Microneedles 2025 Conference. STOCKHOLM, SWEDEN, March 31, 2025 /⁨EINPresswire.com⁩/ -- Ascilion AB ("Ascilion") the …

Distribution channels: Beauty & Hair Care, Business & Economy ...
Published on March 31, 2025 - 07:30 GMT

New Book 'Late To Your Own Funeral' Aims to Transform the Conversation around Death for Younger Generations

Guide Offers Readers Practical and Relevant Estate Planning Strategies ATLANTA, GA, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- Rachel Donnelly, founder and CEO of AfterLight, has released "Late To Your Own Funeral," a comprehensive …

Distribution channels: Banking, Finance & Investment Industry, Book Publishing Industry ...
Published on March 31, 2025 - 03:00 GMT

Global Cannabis Cosmetics Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034

The Business Research Company's Cannabis Cosmetics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /⁨EINPresswire.com⁩/ -- The cannabis cosmetics market has …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 03:00 GMT

In-Depth Analysis of the Cannabis Infused Products Market: Key Drivers, Trends, Opportunities, and Forecast 2025-2034

The Business Research Company's Cannabis-Infused Products Global Market Report 2025 – Market Size, Trends, And Global Forecast 2023-2032 LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /⁨EINPresswire.com⁩/ -- The Global Forecast: What …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:30 GMT

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:30 GMT

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in H2 2025 Raised $140 Million in Gross Proceeds in Upsized IPO in …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:30 GMT

Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

Upon close of merger and $78.9mm concurrent private placement from a syndicate of leading healthcare-dedicated investors, completed transformation to a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:15 GMT

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

MINNEAPOLIS and BRISBANE, Australia, March 31, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:10 GMT

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:00 GMT

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025

- Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver de-targeting, in NHP study - - Preclinical murine data strengthen case for specifically targeting …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:00 GMT

Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives

AVA6000 Phase 1b expansion cohorts enrolling with data targeted for later in 2025 AVA6103 IND-enabling studies underway with a Phase 1 trial anticipated to begin in the first quarter of 2026 Multiple presentations at the AACR Annual Meeting highlight the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:00 GMT

Venus Concept Announces Fourth Quarter and Fiscal Year 2024 Financial Results

TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2024. Summary of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:00 GMT

Ocular Therapeutix™ to Participate in Two Investor Conferences in April

BEDFORD, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that the Company will participate in two investor conferences …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:00 GMT

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

– FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track – – Enrolling approximately one patient per week across the RESET™ clinical development program since ACR Convergence presentation in November 2024 with 33 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 11:00 GMT

Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates

Completed enrollment of Phase 2 AMPLIFY-7P randomized study; disease-free survival (“DFS”) event-driven interim analysis expected in Q3 2025 Aligned with U.S. Food and Drug Administration (“FDA”) on key elements of planned ELI-002 Phase 3 study design, …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...